Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Remogliflozin_etabonate> ?p ?o. }
Showing items 1 to 56 of
56
with 100 items per page.
- Remogliflozin_etabonate abstract "Remogliflozin etabonate (INN/USAN) is a proposed drug for the treatment of type 2 diabetes being investigated by GlaxoSmithKline. Remogliflozin is now being developed by BHV Pharma.[citation needed]".
- Remogliflozin_etabonate atcPrefix "none".
- Remogliflozin_etabonate casNumber "442201-24-3".
- Remogliflozin_etabonate fdaUniiCode "TR0QT6QSUL".
- Remogliflozin_etabonate iupacName "5-methyl-4-[4-(1-methylethoxy)benzyl]-1-(1-methylethyl)-1H-pyrazol-3-yl 6-O-(ethoxycarbonyl)-β-D-glucopyranoside".
- Remogliflozin_etabonate thumbnail Remogliflozin_etabonate_structure.svg?width=300.
- Remogliflozin_etabonate wikiPageID "18775455".
- Remogliflozin_etabonate wikiPageRevisionID "603490312".
- Remogliflozin_etabonate atcPrefix "none".
- Remogliflozin_etabonate c "26".
- Remogliflozin_etabonate casNumber "442201".
- Remogliflozin_etabonate chembl "494323".
- Remogliflozin_etabonate h "38".
- Remogliflozin_etabonate hasPhotoCollection Remogliflozin_etabonate.
- Remogliflozin_etabonate iupacName "5".
- Remogliflozin_etabonate kegg "D10055".
- Remogliflozin_etabonate molecularWeight "522.586".
- Remogliflozin_etabonate n "2".
- Remogliflozin_etabonate o "9".
- Remogliflozin_etabonate routesOfAdministration "Oral".
- Remogliflozin_etabonate smiles "OC1COCOcc2Cc3cccOCC".
- Remogliflozin_etabonate unii "TR0QT6QSUL".
- Remogliflozin_etabonate verifiedfields "changed".
- Remogliflozin_etabonate verifiedrevid "401621521".
- Remogliflozin_etabonate subject Category:Glucosides.
- Remogliflozin_etabonate subject Category:Phenol_ethers.
- Remogliflozin_etabonate subject Category:Pyrazoles.
- Remogliflozin_etabonate subject Category:SGLT2_inhibitors.
- Remogliflozin_etabonate type Abstraction100002137.
- Remogliflozin_etabonate type Chemical114806838.
- Remogliflozin_etabonate type Compound114818238.
- Remogliflozin_etabonate type Element114840755.
- Remogliflozin_etabonate type Glucoside114887801.
- Remogliflozin_etabonate type Glucosides.
- Remogliflozin_etabonate type Glycoside114887305.
- Remogliflozin_etabonate type Material114580897.
- Remogliflozin_etabonate type Matter100020827.
- Remogliflozin_etabonate type OrganicCompound114727670.
- Remogliflozin_etabonate type Part113809207.
- Remogliflozin_etabonate type PhenolEthers.
- Remogliflozin_etabonate type PhysicalEntity100001930.
- Remogliflozin_etabonate type Quintessence114847103.
- Remogliflozin_etabonate type Relation100031921.
- Remogliflozin_etabonate type Substance100019613.
- Remogliflozin_etabonate type Drug.
- Remogliflozin_etabonate type DrugProduct.
- Remogliflozin_etabonate type FunctionalSubstance.
- Remogliflozin_etabonate comment "Remogliflozin etabonate (INN/USAN) is a proposed drug for the treatment of type 2 diabetes being investigated by GlaxoSmithKline. Remogliflozin is now being developed by BHV Pharma.[citation needed]".
- Remogliflozin_etabonate label "Remogliflozin etabonate".
- Remogliflozin_etabonate sameAs m.04gtpt3.
- Remogliflozin_etabonate sameAs Q7312052.
- Remogliflozin_etabonate sameAs Q7312052.
- Remogliflozin_etabonate sameAs Remogliflozin_etabonate.
- Remogliflozin_etabonate wasDerivedFrom Remogliflozin_etabonate?oldid=603490312.
- Remogliflozin_etabonate depiction Remogliflozin_etabonate_structure.svg.
- Remogliflozin_etabonate isPrimaryTopicOf Remogliflozin_etabonate.